Table 1. MR results of body fat indexes on the risk of BCa.
Exposure | Method | No. of SNPs | p | OR (95% CI) | p −het | p - intercept | p −global | p −steiger | F statistic |
---|---|---|---|---|---|---|---|---|---|
Whole body fat mass | MR Egger | 261 | 0.966 | 1.020 (0.416–2.502) | 0.377 | 0.358 | |||
Weighted median | 261 | 0.004 | 1.931 (1.237–3.014) | ||||||
Inverse variance weighted | 261 | 0.006 | 1.518 (1.128–2.042) | 0.379 | 0.000 | 94.983 | |||
Simple mode | 261 | 0.133 | 2.726 (0.740–10.047) | ||||||
Weighted mode | 261 | 0.043 | 2.495 (1.032–6.032) | ||||||
MR-PRESSO (raw) | 261 | 0.004 | 1.534 (1.243–1.824) | 0.505 | |||||
Leg fat mass (right) | MR Egger | 267 | 0.304 | 1.790 (0.592–5.416) | 0.452 | 0.991 | |||
Weighted median | 267 | 0.004 | 2.301 (1.305–4.059) | ||||||
Inverse variance weighted | 267 | 0.002 | 1.779 (1.246–2.540) | 0.469 | 0.000 | 93.140 | |||
Simple mode | 267 | 0.457 | 1.813 (0.379–8.674) | ||||||
Weighted mode | 267 | 0.134 | 2.434 (0.764–7.751) | ||||||
MR-PRESSO (raw) | 267 | 0.001 | 1.799 (1.447–2.150) | 0.573 | |||||
Leg fat mass (left) | MR Egger | 266 | 0.197 | 2.126 (0.678–6.672) | 0.152 | 0.725 | |||
Weighted median | 266 | 0.005 | 2.434 (1.307–4.532) | ||||||
Inverse variance weighted | 266 | 0.004 | 1.751 (1.202–2.551) | 0.161 | 0.000 | 94.237 | |||
Simple mode | 266 | 0.359 | 2.120 (0.427–10.512) | ||||||
Weighted mode | 266 | 0.111 | 2.491 (0.814–7.621) | ||||||
MR-PRESSO (raw) | 266 | 0.002 | 1.771 (1.404–2.138) | 0.264 | |||||
Arm fat mass (right) | MR Egger | 255 | 0.941 | 1.033 (0.436–2.446) | 0.600 | 0.245 | |||
Weighted median | 255 | 0.003 | 2.089 (1.283–3.399) | ||||||
Inverse variance weighted | 255 | 0.001 | 1.672 (1.247–2.243) | 0.594 | 0.000 | 95.852 | |||
Simple mode | 255 | 0.106 | 2.868 (0.803–10.241) | ||||||
Weighted mode | 255 | 0.048 | 2.635 (1.014–6.843) | ||||||
MR-PRESSO (raw) | 255 | 0.000 | 1.680 (1.393–1.967) | 0.688 | |||||
Arm fat mass (left) | MR Egger | 253 | 0.736 | 1.166 (0.477–2.851) | 0.180 | 0.464 | |||
Weighted median | 253 | 0.001 | 2.230 (1.404–3.541) | ||||||
Inverse variance weighted | 253 | 0.003 | 1.597 (1.175–2.169) | 0.186 | 0.000 | 96.172 | |||
Simple mode | 253 | 0.086 | 2.965 (0.863–10.190) | ||||||
Weighted mode | 253 | 0.024 | 2.709 (1.145–6.408) | ||||||
MR-PRESSO (raw) | 253 | 0.001 | 1.642 (1.340–1.945) | 0.222 | |||||
Trunk fat mass | MR Egger | 270 | 0.975 | 0.986 (0.395–2.460) | 0.072 | 0.460 | |||
Weighted median | 270 | 0.014 | 1.736 (1.116–2.700) | ||||||
Inverse variance weighted | 270 | 0.040 | 1.366 (1.014–1.841) | 0.074 | 0.000 | 93.476 | |||
Simple mode | 270 | 0.153 | 2.506 (0.713–8.816) | ||||||
Weighted mode | 270 | 0.081 | 2.405 (0.901–6.418) | ||||||
MR-PRESSO (raw) | 270 | 0.033 | 1.375 (1.082–1.667) | 0.116 |
Notes.
- BCa
- bladder cancer
- IVW
- inverse variance weighted
- OR
- odds ratio
- CI
- confidence intervals
- p-het
- p value for heterogeneity using Cochran Q test
- p-intercept
- p value for MR-Egger intercept
- MR-PRESSO
- Mendelian randomization-pleiotropy residual sum outlier
- p-global
- p value for MR-PRESSO global test
- p-steiger
- p value for MR-Steiger test
- SNP
- single-nucleotide polymorphism